Using metalloproteins to create new drugs more efficiently
Metalloprotein catalysts for asymmetric synthesis
This study is working on creating special catalysts that help make medicines more efficiently and accurately, which could lead to better and safer drugs for patients in the future.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Dallas NIH-funded |
| Lab location | 1 site (Richardson, United States) |
| Project ID | NIH-10810651 on NIH RePORTER |
What this research studies
This research focuses on developing metalloprotein catalysts that can enhance the synthesis of pharmaceuticals by improving the selectivity and efficiency of chemical reactions. By leveraging the unique properties of enzymes, particularly myoglobin, the project aims to create new methods for forming complex organic molecules that are essential for drug development. The approach involves exploring new chemical transformations that can lead to the production of optically active compounds, which are crucial for effective medications. Patients may benefit indirectly as these advancements could lead to more effective and safer drugs.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals who require new or improved medications for their health conditions.
Not a fit: Patients who are not seeking new treatments or who do not require medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more efficient and targeted drugs, improving treatment options for various medical conditions.
How similar studies have performed: Other research has shown promise in using enzyme-based catalysts for drug synthesis, indicating that this approach has potential for success.
Where this research is happening
Richardson, United States
- University of Texas Dallas — Richardson, United States (Active)
Researchers
- Principal investigator: Fasan, Rudi — University of Texas Dallas
- Study coordinator: Fasan, Rudi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.